# AMG 827 in Subjects With Psoriatic Arthritis

> **NCT01516957** · PHASE2 · TERMINATED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 168 (actual)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** AMG 827 140
- **DRUG:** Placebo
- **DRUG:** AMG 827 280
- **DRUG:** AMG 827 210

## Key facts

- **NCT ID:** NCT01516957
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2012-09
- **Final completion:** 2015-09
- **Target enrollment:** 168 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2020-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01516957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01516957, "AMG 827 in Subjects With Psoriatic Arthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01516957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*